The prevalence and clinical profile of cardiac troponin T gene mutations were evaluated in 150 consecutive patients with hypertrophic cardiomyopathy from the well-defined geographic region of Tuscany. Troponin T mutations had a low prevalence (3.3%; including a newly described Phe110Leu mutation) and were associated with heterogeneous clinical expression and outcome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjcard.2003.08.031 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!